Evidence map›Paper›PMID 17711449›Full record

ArticleHistopathology2007

Increased cytoplasmic level of migfilin is associated with higher grades of human leiomyosarcoma.

D J Papachristou, V Gkretsi, Y Tu, X Shi, K Chen, H Larjava, U N M Rao, C Wu

Open access · greenAbstract read
In one paragraph

Article in Histopathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

D J PapachristouDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
V Gkretsi
Y Tu
X Shi
K Chen
H Larjava
U N M Rao
C Wu
University of British Columbia · CAUniversity of Pittsburgh · US

Funding

PINCH-1 Interactions and FunctionsR01GM065188 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WU, CHUANYUE · 2002 to 2014
$3.3M
The PINCH-ILK-parvin complexes in glomerular cellsR01DK054639 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WU, CHUANYUE · 1998 to 2010
$3.2M
Periodontitis caused by kindlin-1 mutationsR01DE016099 · NIDCR · UNIVERSITY OF BRITISH COLUMBIA · PI LARJAVA, HANNU SAKARI · 2005 to 2009
$1.4M
NIDCR NIH HHS DE016099NIDCR NIH HHS R01 DE016099NIDDK NIH HHS DK54639NIDDK NIH HHS R01 DK054639NIGMS NIH HHS GM65188NIGMS NIH HHS R01 GM065188
6 · The paper itself

Abstract

aimsLeiomyosarcomas (LMS) are malignant neoplasms composed of cells that exhibit distinct smooth muscle differentiation. The molecular and cytogenetic features of LMS are complex and no consistent aberrations have been reported to date. Mitogen inducible gene-2 (Mig-2), kindlin and migfilin are recently identified cell-matrix adhesion proteins. The aim was to determine the expression and distribution of these proteins in human smooth muscle tumours of somatic soft tissue. METHODS AND

resultsImmunohistochemistry was performed on a human LMS tissue microarray and on sections of human leiomyomas (LM) and normal smooth muscle. Migfilin was barely detectable in normal smooth muscle cells, whereas increased levels of migfilin were observed in the majority of LM and LMS. Furthermore, the cytoplasmic level of migfilin was strongly associated with higher tumour grades. Additionally, the cytoplasmic levels of migfilin and Mig-2 were correlated with each other, suggesting an association between the two in the cytoplasm. Kindlin was expressed in normal smooth muscle, LM and LMS, and its level did not correlate with tumour grade.

conclusionsOur results suggest a role for cytoplasmic migfilin in the progression of LMS and identify cytoplasmic migfilin as a potentially important biological marker for human LMS progression.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorBiopsyCell Adhesion MoleculesCytoplasmCytoskeletal ProteinsFemaleHumansLeiomyosarcomaMaleMembrane ProteinsMicroarray AnalysisMiddle AgedMuscle, SmoothBiomarkers, TumorCell Adhesion MoleculesCytoskeletal ProteinsFBLIM1 protein, humanFERMT1 protein, humanFERMT3 protein, humanMembrane ProteinsNeoplasm Proteins

Identifiers

PMID17711449
PMCPMC2768333
OpenAlexW2049635996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.